A method for inhibiting cancer cell proliferation or increasing cancer cell apoptosis

Details for Australian Patent Application No. 2005222626 (hide)

Owner Karaolis, D.

Inventors Karaolis, David K.R.; Raufman, JeanPierre

Agent FB Rice

Pub. Number AU-B-2005222626

PCT Pub. Number WO2005/089777

Priority 60/552,721 15.03.04 US; 60/563,692 20.04.04 US

Filing date 15 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 20 May 2010

International Classifications

A61K 31/7084 (2006.01) - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/089777 Priority application(s): WO2005/089777

20 May 2010 Application Accepted

  Published as AU-B-2005222626

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005222627-Tetra-cyclic carboline derivatives for inhibiting angiogenesis

2005222622-SNS-595 and methods of using the same